Persones / Equip Humà

Clàudia Fortuny Guasch

Buscador de publicacions

Publicacions

  • Pons-Tomàs G, Pino-Ramirez RM, Soler-García a, Launes-Montana C, Irene Martínez de Albéniz, Rios-Barnés M, Melé-Casas M, Hernández-García M, Manuel Monsonis Cabedo, Gene-Giralt A, Fernández de Sevilla-Estrach M, García-García JJ, Fortuny-Guasch C and Fumadó V.

    Deciphering the Longevity and Levels of SARS-CoV-2 Antibodies in Children: A Year-Long Study Highlighting Clinical Phenotypes and Age-Related Variations

    PATHOGENS . 13(8): .

    [doi:10.3390/pathogens13080622]

  • Gamell Fullà A, Velasco E, López-Ramos MG, Rios-Barnés M, Simó-Nebot S, Fumadó V, Noguera-Julian A and Fortuny-Guasch C.

    Off-label use of dalbavancin in children: a case series

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 79(8): 2062-2067. Nº de cites: 2

    [doi:10.1093/jac/dkae212]

  • Turkova A, Chan MK, Kityo C, Kekitiinwa AR, Musoke P, Violari A, Variava E, Archary M, Cressey TR, Chalermpantmetagul S, Sawasdichai K, Ounchanum P, Kanjanavanit S, Srirojana S, Srirompotong U, Welch S, Bamford A, Epalza C, Fortuny-Guasch C, Colbers A, Nastouli E, Walker S, Carr D, Conway M, Spyer MJ, Parkar N, White I, Nardone A, Thomason MJ, Ferrand RA, Giaquinto C and Ford D.

    D3/Penta 21 clinical trial design: A randomised non-inferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV-1 infection, aged 2 to 15 years

    Contemporary Clinical Trials . 142: 107540-107540. Nº de cites: 5

    [doi:10.1016/j.cct.2024.107540]

  • Agüera M, Soler-García a, Alejandre-Galobardes C, Moussalam-Merino S, Sala-Castellví P, Pons G, Penela-Sánchez D, González-Grado C, Alsina-Rosell J, Climent C, Esteva-Afonso C, Fortuny-Guasch C, Fernández de Sevilla-Estrach M, García-García JJ, Brotons-de los Reyes P, Balaguer A, Estrada J, Jordán-García I, Munoz-Almagro C and Launes-Montana C.

    Nirsevimab immunization's real-world effectiveness in preventing severe bronchiolitis: A test-negative case-control study

    PEDIATRIC ALLERGY AND IMMUNOLOGY . 35(6): . Nº de cites: 17

    [doi:10.1111/pai.14175]

  • Rios-Barnés M, Velasco E, Fortuny-Guasch C, Benavides M, Baquero-Artigao F, Muga O, Del Valle R, Frick MA, Bringué X, Herrero S, Vilas J, Alonso-Ojembarrena A, Castells-Vilella L, Rojo P, Blázquez-Gamero D, Esteva-Afonso C, Sánchez E, Alarcon A and Noguera-Julian A.

    Renal Function Impairment in Children With Congenital Cytomegalovirus Infection: A Cross-sectional Study

    PEDIATRIC INFECTIOUS DISEASE JOURNAL . 43(3): 257-262.

    [doi:10.1097/INF.0000000000004176]

  • Alarcon A, de Vries LS, Parodi A, Arnáez J, Cabañas F, Steggerda SJ, Rebollo M, Ramenghi L, Dorronsoro I, López-Azorín M, Schneider J, Noguera-Julian A, Rios-Barnés M, Recio M, Bickle-Graz M, Martínez-Biarge M, Fortuny-Guasch C, García-Alix A and Truttmann AC.

    Neuroimaging in infants with congenital cytomegalovirus infection and its correlation with outcome: emphasis on white matter abnormalities

    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION . 109(2): 151-158. Nº de cites: 23

    [doi:10.1136/archdischild-2023-325790]

  • Epalza, C, Valadés-Alcaraz, A, González-Alba, JM, Beltrán-Pavez, C, Gutiérrez-López, M, Rubio-Garrido, M, Fortuny-Guasch C, Frick, MA, Medina, LM, Moreno, S, Sanz, J, Rojo, P, Navarro, ML and Holguín, A.

    Transmitted Drug Resistance and HIV Diversity Among Adolescents Newly Diagnosed With HIV in Spain

    PEDIATRIC INFECTIOUS DISEASE JOURNAL . 43(1): 40-48. Nº de cites: 1

    [doi:10.1097/INF.0000000000004138]

  • Blanco Y, Escudero D, Lleixà C, Llufriu S, Egri N, García RR, Alba M, Aguilar E, Artola M, Aldea Novo M, Alvarez S, Caballero E, Cabrera-Maqueda JM, Fonseca E, Guasp M, Hernando A, Martinez-Hernandez E, Olivé-Cirera G, Lopez-Contreras J, Martín-Aguilar L, Martinez-Martinez L, Rombauts A, Rodés M, Sabater L, Sepulveda M, Solana E, Tejada-Illa C, Vidal-Fernández N, Vilella A, Fortuny-Guasch C, Armangue-Salvador T, Dalmau JO, Querol L and Saiz A.

    mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple Sclerosis

    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION . 10(6): . Nº de cites: 5

    [doi:10.1212/NXI.0000000000200163]

  • Soler-García a, Gamell Fullà A, Manuel Monsonis Cabedo, Korta-Murua JJ, Espiau M, Rincón-López E, Rodríguez-Molino P, Pérez-Porcuna T, Bustillo-Alonso M, Santiago B, Tebruegge M and Noguera-Julian A.

    The Value of the Second QuantiFERON-TB Gold-Plus Antigen Tube at Diagnosis and at Treatment Completion in Spanish Children With Tuberculosis

    PEDIATRIC INFECTIOUS DISEASE JOURNAL . 42(11): 1017-1020. Nº de cites: 2

    [doi:10.1097/INF.0000000000004058]

  • Armangue-Salvador T, Olivé-Cirera G, Martínez-Hernandez E, Rodes M, Peris-Sempere V, Guasp M, Ruiz R, Palou E, González A, Marcos MÁ, Erro ME, Bataller L, Corral-Corral Í, Planagumà J, Caballero E, Vlagea A, Chen J, Bastard P, Materna M, Marchal A, Abel L, Cobat A, Alsina L, Fortuny-Guasch C, Saiz A, Mignot E, Vanderver A, Casanova JL, Zhang SY and Dalmau J.

    Neurologic complications in herpes simplex encephalitis: clinical, immunological and genetic studies.

    BRAIN . 146(10): 4306-4319. Nº de cites: 43

    [doi:10.1093/brain/awad238]